EC approves Pfizer's maraviroc

The European Commission approved an MAA from PFE for Celsentri maraviroc for treatment-experienced adult patients infected with CC chemokine receptor 5 ( CCR5)-tropic HIV-1. The CCR5 antagonist is mar...